 |
 |
 |
 |
 |
 |
 |
 |
Efavirenz/Tenofovir/FTC (Atripla)
Overview
- A Clinical Overview of Efavirenz/Tenofovir/FTC (Atripla) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Prescribing Information for Efavirenz/Tenofovir/FTC (Atripla) (PDF) (June 2008)
From Bristol-Myers Squibb Company and Gilead Sciences, Inc. - Atripla (Efavirenz/Emtricitabine/
Tenofovir DF, EFV/FTC/TDF) (January/February 2008)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network - Approval of Atripla (July 12, 2006)
From U.S. Food and Drug Administration
News
- Approval for Once-A-Day HIV Pill (December 17, 2007)
In BBC News Online, from BBC News - FDA Approves Gilead, Bristol-Myers Squibb Once-a-Day Combination Antiretroviral Pill (July 13, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Single-Pill, Once-Daily HIV Drug Regimen Submitted for FDA Approval (April 28, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Data Supports Bioequivalence for Once-Daily, Single-Pill, Fixed-Dose Combination of Sustiva and Truvada, Drug Companies Announce (January 9, 2006)
Filing of a new drug application is expected in the second quarter of 2006.
To read PDF, click here
From Bristol-Myers Squibb Company and Gilead Sciences, Inc. - Gilead's Fixed-Dose Combination of Truvada + Efavirenz Not Yet Bioequivalent to Drugs Alone (August 10, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Clinical Management
Clinical Management
  |
  |